Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 1.11% | 62.18 | 0.0% | $1999.69m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.18% | 599.47 | 2.5% | $1212.04m | |
| GILD | Gilead Sciences, Inc. | -3.43% | 75.16 | 1.0% | $972.03m | |
| NVAX | Novavax, Inc. | 14.73% | 52.82 | 102.0% | $711.68m | |
| AMGN | Amgen, Inc. | -1.22% | 226.91 | 1.3% | $619.06m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.46% | 286.64 | 1.9% | $592.02m | |
| BIIB | Biogen, Inc. | -1.84% | 301.45 | 1.6% | $385.60m | |
| ILMN | Illumina, Inc. | 0.65% | 365.41 | 3.5% | $384.25m | |
| SRNE | Sorrento Therapeutics, Inc. | -0.99% | 5.00 | 1.8% | $320.03m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.82% | 118.92 | 2.0% | $296.17m | |
| SGEN | Seattle Genetics, Inc. | 1.15% | 159.02 | 6.1% | $258.80m | |
| A | Agilent Technologies, Inc. | 2.01% | 89.91 | 1.6% | $212.68m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.79% | 107.39 | 4.3% | $185.56m | |
| MGNX | MacroGenics, Inc. | 9.67% | 21.10 | 6.2% | $174.18m | |
| INCY | Incyte Corp. | -0.16% | 101.75 | 2.5% | $166.58m |
Company Profile
Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.